- Home
- TKNO vs RDIB Comparison
TKNO vs RDIB Comparison
Compare TKNO & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKNO | RDIB |
|---|---|---|
| Founded | 1996 | 1937 |
| Country | United States | United States |
| Employees | N/A | 2025 |
| Industry | Medicinal Chemicals and Botanical Products | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 256.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TKNO | RDIB |
|---|---|---|
| Price | $3.14 | $11.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 233.8K | 5.0K |
| Earning Date | 03-03-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $39,801,000.00 | ★ $211,292,000.00 |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $10.52 | $13.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.50 | 7.11 |
| 52 Week Low | $3.01 | $5.81 |
| 52 Week High | $10.37 | $14.95 |
Technical Indicators
Market Signals| Indicator | TKNO | RDIB |
|---|---|---|
| Relative Strength Index (RSI) | 25.93 | 48.76 |
| Support Level | $3.01 | $10.73 |
| Resistance Level | $3.54 | $11.55 |
| Average True Range (ATR) | 0.32 | 0.34 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 11.55 | 30.43 |
Price Performance
Historical ComparisonAbout TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.